PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,940 | +80.1% | 30,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $4,965 | -83.0% | 30,000 | 0.0% | 0.00% | -80.0% |
Q1 2023 | $29,280 | -6.2% | 30,000 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $31,200 | -10.9% | 30,000 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $35,000 | -37.5% | 30,000 | 0.0% | 0.01% | -33.3% |
Q2 2022 | $56,000 | -38.5% | 30,000 | 0.0% | 0.01% | -25.0% |
Q1 2022 | $91,000 | -19.5% | 30,000 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $113,000 | -27.1% | 30,000 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $155,000 | +34.8% | 30,000 | 0.0% | 0.02% | +40.0% |
Q2 2021 | $115,000 | +49.4% | 30,000 | 0.0% | 0.02% | +36.4% |
Q1 2021 | $77,000 | +2.7% | 30,000 | 0.0% | 0.01% | -8.3% |
Q4 2020 | $75,000 | +21.0% | 30,000 | 0.0% | 0.01% | +9.1% |
Q3 2020 | $62,000 | -33.3% | 30,000 | 0.0% | 0.01% | -35.3% |
Q2 2020 | $93,000 | +36.8% | 30,000 | 0.0% | 0.02% | +6.2% |
Q1 2020 | $68,000 | -37.6% | 30,000 | 0.0% | 0.02% | -15.8% |
Q4 2019 | $109,000 | +6.9% | 30,000 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $102,000 | – | 30,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |